Morbilidad asociada al soporte transfusional en pacientes pediátricos con leucemia aguda en el Instituto Nacional de Cancerología

Robins L General principles of the epidemiology of childhood cancer. In: Pizzo P, Poplack D. Principles and Practice of Pediatric Oncology. Third Edition. Lippincott Raven Publishers. Philadelpia-New York. 1997. p. 1-11.

Lanzkowsky Ph. Leukemias. In: Manual of Pediatric Hematology and Oncology. Third Edition. Academic Press. 1999. p. 359-413.

Pui C-H. Childhood Leukemias. N Engl J Med 1995;332:561-585. https://doi.org/10.1056/NEJM199506153322407

Argolin J, Poplack D. Acute lymphoblastin leukemia. In: Pizzo Py Poplack D. Principles and Practice of Pediatric Oncology. Third Edition. Lippincott Raven Publishers. Philadelpia-New York. 1997. p. 409-62.

Golub Ty Weinstein H, Grier H. Acute myelogenus leukemia. In: Pizzo P} Poplack D. Principles and Practice of Pediatric Oncology. Third Edition. Lippincott Raven Publishers. Philadelpia-New York. 1997. p.463-82.

Buchanan G. Hematologic supportive care of pediatric cancer patiente. In: Pizzo P, Poplack D. Principles and Practice of Pediatric Oncology. Third Edition. Lippincott Raven Publishers. Philadelpia-New York. 1997. p.1051-68.

Rossi Ey Simon T. Trombocytopenia and platelets transfusion. In: Rossi E., Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.257-62.

Heyman M, Schijfer C. Platelet transfusion in patient receiving chemotherapy. In: Rossi E, Simon LPy Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.263-74.

Webb Jy Anderson K. Transfusion support in acute leukemias. Sem Oncol 1994;24:141-46.

Walter D. Leukoreduced blood components laboratory and clinical. In: Rossi E, Simon LP, Moss Gy Goult S. Principles of transfusion medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.353-74.

Leitman S. Leukocyte inactivation by blood irradiation. In: Rossi E, Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.375-83.

Bowden R, Slichter S, Sayers M et al. Use of leukocyte depleted platelets and citomegalovirus seronegative red blood cells for prevention of primary citomegalovirus infection after marrow transplant. Blood 1991; 78: 246-50. https://doi.org/10.1182/blood.V78.1.246.246

Lanzkowsky Ph. Supportive care and manage ment of oncology emergencies. In: Manual of Pediatric Hematology and Oncology. Third Edition. Academic Press. 1999. p. 669-718.

Lorenzo My Davis JW, Negin S, Kaups K, Parks S, Brubaker D etal. Can ringer's lactate be used safely with blood transfusions?. Am J Surg 1998;175:308-310. https://doi.org/10.1016/S0002-9610(98)00011-7

Manno S. Novedades en transfusiología. Clin Ped N Am 1997;4:743-55.

Shulman I. Transmission of parasitic infections by blood transfusion. In: Rossi E, Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.733-38.

Bordin J, Heddle N, Blajchman. Biologic effects of leukocytes present in tranfused cellular blood products. Blood 1994; 84: 1703-21. https://doi.org/10.1182/blood.V84.6.1703.1703

Marwijk M, Prooijein H, Moes M et al. Use of leukocyte depleted platelet concentrates for the prevention of refractoriness and primary HLA alloinmunization: A prospective randomized trial. Blood 1991;77:201-5. https://doi.org/10.1182/blood.V77.1.201.201

Barnard D, FeusnerJ, Wolff L. Blood component therapy. In: Ablin A. Supportive Care of Children With Cancer. Second edition. The Johns Hopkins University Press. Baltimore. 1997. p.37-46.

Roberts G, SacherR. Transfusion associated graft versus host disease. In: Rossi E, Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.785-802.

MoroffG, George V, Siegl A et al. The influence or irradiation on stored platelets. Transfusion 1986;26:453-6. https://doi.org/10.1046/j.1537-2995.1986.26587020124.x

Anderson K, Weinstein H. Transfusion associated graft versus host disease. N Eng J Med 1990; 323: 315-21. https://doi.org/10.1056/NEJM199002013220507

GreenbaumB. Tranfusion associated graft versus host disease: Historical perspectives, incidence and corrent use of irradiated blood products. J Clin Oncol 1991;9:1889-1902. https://doi.org/10.1200/JCO.1991.9.10.1889

Norol F, Bierfling PH, Roudot-Thoraval F, Le Coeur F, Rieux C, Lavaux A et al. Platelet transfusion: a dose response study. Blood 1998;92(4):1448-53. https://doi.org/10.1182/blood.V92.4.1448

Kruskall M. The perils of platelet transfusions. N Eng J Med 1997;337(26):1914-15. https://doi.org/10.1056/NEJM199712253372609

Sintnicolaas K, Sizoo W et al. Delayed allo inmunization by random single donor plateletn transfusion. A randomized study to compare single donor and multiple donor platelet transfusions in cancer patient with severe thrombocytopenia. Lancet 1981;1:750-53. https://doi.org/10.1016/S0140-6736(81)92626-X

Schiffer C, Slichter S. Platelet transfusions from single donors. N Eng J Med 1982;307:245-47. https://doi.org/10.1056/NEJM198207223070410

Simon T. Plateletpheresis. In: Rossi E., Simon LP., Moss G, Goult S. Principles of transfusion medicine. Second edition. Baltimore Williams-Wilkins; 1996. Pg.547-50.

Wandt H, Frank M, Ehninger G et al. Safety and cost effectiveness or a lOxlO/lt trigger for profilactic platelet transfusion compared with the traditional 20x10/lt trigger: a prospective comparative trial in 105 patients with leukemia. Blood 1998;91:3601-06. https://doi.org/10.1182/blood.V91.10.3601

Gmur J, Burger J, Schanz U et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 1991;338:1223-26. https://doi.org/10.1016/0140-6736(91)92098-M

Williamson L, Wimpers J, Williamson P et al. Bedside filtration of blood products in the prevention of HLA alloinmunization: a rando mized study. Blood 1994;83:3028-35. https://doi.org/10.1182/blood.V83.10.3028.3028

Heddle N, Blajchman M. The leukodepletion of cellular blood products in the prevention of HLA alloinmunization and refractoriness to allogenic platelet transfusion. Blood 1995;85:603-5. https://doi.org/10.1182/blood.V85.3.603.bloodjournal853603

Sintnilaas K, Marwijk M, Prooijein H et al. Leukocyte depletion of random single donor platelet transfusions does not prevent secundary human leukocyte atigen alloinmunization and refractoriness: a randomized prospective study. Blood 1995;85:824-28. https://doi.org/10.1182/blood.V85.3.824.bloodjournal853824

Saarinen U, Kekomaki R, Siimes M, et al. Effective prophylaxis against platelet refratoriness in multitransfused patients by used or leucocyte free bloods components. Blood 1990;75:512-17. https://doi.org/10.1182/blood.V75.2.512.512

Friedberg R, Donnelly S, Boyd J et al. Clinical and blood bank factors in the management of platelet refractoriness and alloinmunization. Blood 1993;8:3428-34. https://doi.org/10.1182/blood.V81.12.3428.3428

Brecher M. Hemolytic transfusion reactions. In: Rossi E, Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.747-64.

Stack J, Judge J, Snyder E. Febrile andnoinmune transfusion reaction. In: Rossi E, Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. P. 773-84.

Pierce R, Reich L, Mayer K. Hemolysis following platelet transfusions from ABO incompatible donors. Transfusion 1985;25:60-62. https://doi.org/10.1046/j.1537-2995.1985.25185116506.x

Carreras L. Efectos secundarios inmunológicos y no inmunológicos de la hemoterapia. En: Enciclopedia Iberoamericana de Hematología. Ediciones Universidad de Salamanca. 1992. Tomo IV. p.279-92.

The trial to reduce alloinmunization to platelets study group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent allo inmunization and refractoriness to platelet transfusion. NEng JMed 1997;337(26):1861-9. https://doi.org/10.1056/NEJM199712253372601

Hamerschlack N. Enfermedades infecciosas transmitidas por transfusión. En: Enciclopedia Iberoamericana de Hematología. Ediciones Universidad de Salamanca. 1992. Tomo TV. p.293-301.

Alter H. Transfusion transmitted non A, non B and Hepatitis C virus. In: Rossi E, Simon LP, Moss Gt Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. p.687-98.

Busch M. Transfusion associated AIDS. In: Rossi E, Simon LP, Moss Gf Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. 699-708.

Gunter Ky Luban N. Transfusion transmitted Cytomegalovirus and Epstein Barr virus disease. In: Rossi Et Simon LP, Moss G, Goult S. Principles of Transfusion Medicine. Second edition. Baltimore Williams-Wilkins; 1996. 717-32.

Wick M, Moore S, Taswell H. Non A non B hepatitis associated with blood transfusion. Transfusion 1985;25:93-98. https://doi.org/10.1046/j.1537-2995.1985.25285169225.x

Arico M, Maggiore G, Silini E et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994; 84: 2919-22. https://doi.org/10.1182/blood.V84.9.2919.2919

Paul M, Sanders J, Ruggiero F, Andrews T, Ungar D, Eyster E. Chronic hepatitis C virus infection in leukemia survivors: prevalence, viral load, and severity of liver diseas. Blood 1999;93(11):3672-77. https://doi.org/10.1182/blood.V93.11.3672

Regan F, Hewitt P, Barbara J, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20.000 units of blood. BMJ 2000;320:403-6. https://doi.org/10.1136/bmj.320.7232.403

Registro Institucional de Cáncer. Subdirección de Epidemiología, Registro, Investigación Clínica, Promoción y Prevención. Instituto Nacional de Cancerología. 1998.